Central Puerto (NYSE:CEPU – Get Rating) and Biotricity (OTCMKTS:BTCY – Get Rating) are both small-cap oils/energy companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, institutional ownership and profitability.
Profitability
This table compares Central Puerto and Biotricity's net margins, return on equity and return on assets.
Get
Central Puerto alerts:
| Net Margins | Return on Equity | Return on Assets |
| Central Puerto | 16.67% | 7.33% | 4.68% |
| Biotricity | N/A | N/A | N/A |
Analyst Ratings
This is a summary of recent ratings for Central Puerto and Biotricity, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
| Central Puerto | 0 | 0 | 0 | 0 | N/A |
| Biotricity | 0 | 1 | 2 | 0 | 2.67 |
Biotricity has a consensus price target of $5.67, indicating a potential upside of 510.76%. Given Biotricity's higher possible upside, analysts clearly believe Biotricity is more favorable than Central Puerto.
Earnings & Valuation
This table compares Central Puerto and Biotricity's gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
| Central Puerto | $600.19 million | 1.07 | -$7.79 million | $0.66 | 6.45 |
| Biotricity | $7.70 million | 6.25 | -$32.70 million | ($0.63) | -1.47 |
Central Puerto has higher revenue and earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than Central Puerto, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
2.6% of Central Puerto shares are owned by institutional investors. Comparatively, 5.1% of Biotricity shares are owned by institutional investors. 0.1% of Central Puerto shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Risk & Volatility
Central Puerto has a beta of 1.42, meaning that its share price is 42% more volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.69, meaning that its share price is 69% more volatile than the S&P 500.
Summary
Central Puerto beats Biotricity on 8 of the 13 factors compared between the two stocks.
About Central Puerto
(Get Rating)
Central Puerto S.A. generates and sells electric power to private and public customers in Argentina. It also produces steam. As of December 31, 2021, the company owned and operated five thermal generation plants, one hydroelectric generation plant, and seven wind farms with a total installed capacity of 4,809 MW. Central Puerto S.A. was founded in 1898 and is based in Buenos Aires, Argentina.
About Biotricity
(Get Rating)
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
Receive News & Ratings for Central Puerto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Central Puerto and related companies with MarketBeat.com's FREE daily email newsletter.
